However, further research is warranted to fully understand the contribution of SRG3 overexpression to balancing between immune and metabolic homeostasis in adipose tissues and its potential relevance to metabolic diseases such as obesity and type 2 diabetes. This evidence concerns the gene SMARCC1 and type 2 diabetes mellitus.